Jason R. Williams, MD, DABR

home / authors / jason-r-williams-md-dabr

Articles

Ablative technology may generate an immune response that can be enhanced via injected immunotherapy in patients with solid tumors.

Oncolysis/Immunotherapy Shows ‘Significant’ Data in Prostate Cancer

Jason R. Williams, MD, DABR

December 2nd 2024

Ablative technology may generate an immune response that can be enhanced via injected immunotherapy in patients with solid tumors.

Performing ablation and injecting tumor sites with immunotherapy may be “synergistic”, according to Jason R. Williams, MD, DABR.

Ablation Plus Intra-tumoral Therapy May Enhance Immune Responses in Tumors

Jason R. Williams, MD, DABR

November 27th 2024

Performing ablation and injecting tumor sites with immunotherapy may be “synergistic”, according to Jason R. Williams, MD, DABR.

Latest Updated Articles

Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates

Published: September 13th 2024 | Updated: November 25th 2024

Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.

Published: August 9th 2024 | Updated: August 14th 2024

Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets

OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer

Published: June 2nd 2024 | Updated: June 3rd 2024

OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer

Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.

Published: May 6th 2024 | Updated: May 21st 2024

FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications

A 60-Year-Old Woman Treated for RCC Develops a Nonpruritic, Slightly Tender Cutaneous Eruption

Published: December 5th 2011 | Updated: December 29th 2024

A 60-Year-Old Woman Treated for RCC Develops a Nonpruritic, Slightly Tender Cutaneous Eruption

Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes

Published: August 26th 2011 | Updated: December 29th 2024

Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes

OncNursingNews.com

TargetedOnc.com

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.